Tinea Pedis

01Pathophysiology

Tinea pedis is a superficial dermatophyte infection of the feet caused by fungi that possess keratinases, enzymes that digest keratin in the stratum corneum. These organisms, primarily Trichophyton rubrum and T. mentagrophytes, thrive in the dead keratinized tissue of the skin but do not invade living tissue in immunocompetent hosts. This is why the infection remains superficial and why the immune response is relatively limited in most patients.

The warm, moist, occluded environment of the interdigital spaces creates an ideal microclimate for fungal proliferation. Hyperhidrosis and occlusive footwear raise local humidity and temperature, promoting spore germination and hyphal penetration into the stratum corneum. This explains the classic risk profile: the young male athlete wearing closed shoes in a locker room.

The inflammatory response to fungal elements and their metabolic byproducts causes the pruritus, erythema, and scaling seen clinically. In the interdigital type, chronic moisture leads to maceration and fissuring, which can breach the skin barrier and serve as a portal of entry for bacteria, most notably Group A Streptococcus and Staphylococcus aureus. This is a critical clinical connection: tinea pedis is the most common predisposing factor for lower extremity cellulitis, and exam vignettes frequently test this relationship.

In the moccasin variant, T. rubrum elicits a minimal inflammatory response due to its production of mannans, cell wall glycoproteins that suppress local cell-mediated immunity. This results in a chronic, indolent, hyperkeratotic pattern rather than an acute vesicular eruption. The organism essentially "hides" from the immune system, explaining why moccasin-type tinea pedis is notoriously difficult to treat with topical agents alone (the thickened stratum corneum limits drug penetration).

The vesiculobullous variant, typically caused by T. mentagrophytes, produces a vigorous delayed-type hypersensitivity (Type IV) reaction, leading to vesicle and bulla formation on the instep and sole. This variant may also trigger an id reaction (autoeczematization), a secondary eczematous eruption (often on the hands) that is not caused by direct fungal invasion but rather by a systemic immune response to fungal antigens. The id reaction will be KOH-negative at the distant site.

02Classification and Clinical Manifestation

03Diagnostic Workup

The approach to diagnosis begins at the bedside. When the vignette describes a pruritic, scaly foot rash, the best initial test is a KOH preparation. You scrape scale from the leading edge of the lesion (not the center, which may be clearing) onto a glass slide, apply 10 to 20% potassium hydroxide to dissolve keratinocytes, and examine under the microscope. The hallmark finding is septate, branching hyphae. This distinguishes dermatophyte infection from candidiasis (which shows pseudohyphae and budding yeast) and from non-fungal causes of scaling.

If the KOH is negative but your clinical suspicion is high, or if the patient has failed empiric antifungal therapy, the next step is a fungal culture on Sabouraud dextrose agar. This is the gold standard because it identifies the exact species, which can guide therapy and rule out non-dermatophyte molds. However, results take weeks, so treatment is often started empirically while waiting.

A common exam trap is the inclusion of Wood lamp in the answer choices. Remember: Wood lamp examination does not help in tinea pedis. It is only useful for detecting Microsporum species (which cause some tinea capitis cases) and for diagnosing erythrasma (Corynebacterium minutissimum), which produces a coral-red fluorescence. Erythrasma is a common look-alike in the interdigital spaces, and this is a frequently tested distinction.

Skin biopsy with PAS (periodic acid-Schiff) staining is the most sensitive histologic method for identifying fungal elements but is not a first-line or routine test. It appears in vignettes where KOH and culture are negative but the clinical picture is convincing.

04Management and Treatment

For the majority of exam vignettes describing a straightforward interdigital tinea pedis in an otherwise healthy patient, the answer is topical terbinafine applied twice daily for 1 to 2 weeks. Terbinafine is preferred over azoles because it is fungicidal (it kills the organism) rather than fungistatic, and it requires a shorter treatment course. Topical azoles such as clotrimazole and miconazole are acceptable alternatives but need 4 weeks of application.

When the vignette describes a moccasin-type distribution (diffuse, bilateral, hyperkeratotic scaling of the soles and heels), the correct answer shifts to oral terbinafine 250 mg daily for 2 to 4 weeks. Topical agents penetrate poorly through the thickened stratum corneum of the moccasin variant, making systemic therapy necessary. Before initiating oral terbinafine, you must check baseline liver function tests (LFTs) because the drug is hepatically metabolized and carries a small risk of hepatotoxicity. This is a commonly tested point.

Oral itraconazole is the alternative systemic agent. It is a potent CYP3A4 inhibitor, which means it interacts with numerous medications including statins, warfarin, and certain antihypertensives. Exam questions may present a patient on simvastatin with moccasin tinea pedis and ask which drug to avoid (itraconazole, because of the risk of rhabdomyolysis from statin toxicity).

Oral griseofulvin, while historically used for dermatophyte infections, is not first-line for tinea pedis. It is primarily tested in the context of tinea capitis in children, where it remains a classic answer.

A vignette describing a patient with interdigital tinea pedis who then develops fever, erythema, warmth, and swelling of the lower leg is testing the complication of secondary bacterial cellulitis. The next best step is to treat the cellulitis with antibiotics (cephalexin or similar) while concurrently treating the underlying fungal infection. Do not miss the connection between tinea pedis and recurrent lower extremity cellulitis.

For the id reaction, the key management principle is that the distant eczematous eruption (typically on the palms) is treated with topical corticosteroids, while the primary tinea pedis is treated with antifungals. Applying antifungals to the id reaction site is ineffective because there is no fungal infection there. The id reaction resolves once the primary infection is eradicated.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students lose points on tinea pedis questions is by failing to connect interdigital tinea pedis to secondary bacterial cellulitis. When a vignette describes a patient with chronic toe web maceration who then presents with unilateral lower leg erythema, warmth, and swelling, the answer is cellulitis and the underlying predisposing factor is tinea pedis. Students who focus only on the cellulitis and miss the fungal source will select an incomplete management plan.

The second major trap involves the Wood lamp. It appears as a tempting diagnostic answer for any fungal infection, but it does not help in tinea pedis. It is only positive for erythrasma (coral-red) and for Microsporum-related tinea capitis (blue-green). Choosing Wood lamp for a foot rash is a distractor designed to catch students who apply a general rule ("Wood lamp for fungal infections") without understanding its limitations.

Third, watch for the moccasin-type presentation that is described as bilateral, chronic, dry scaling of the soles. Students often mistake this for eczema or psoriasis because it looks non-inflammatory. The giveaway is that the vignette will typically mention concurrent toenail thickening or discoloration (tinea unguium), which strongly points toward a dermatophyte cause. And remember: moccasin-type tinea pedis requires oral antifungal therapy, not topical.

Finally, the id reaction is a classic exam concept. A patient being treated for tinea pedis who develops a new vesicular eruption on the hands is not experiencing a drug reaction or a new fungal infection at the distant site. The KOH at the hand lesion will be negative. Treatment is topical steroids on the hands and continued antifungal therapy for the feet. The id reaction resolves when the primary infection clears. Students who order antifungals for the hand lesion or discontinue treatment thinking it is a drug allergy will get the question wrong.

The core competency being tested is the ability to recognize the clinical subtypes of tinea pedis, select the correct diagnostic test (KOH first, culture to confirm), match the treatment to the severity and subtype (topical for mild interdigital, oral for moccasin or refractory cases), and anticipate the complications (cellulitis, id reaction) that transform a simple dermatology question into a multi-step clinical reasoning problem.